Back

Risk assessment according to the presence of left heart disease phenotype in pulmonary arterial hypertension patients: a multicenter cohort study.

27 August 2023 (15:57 - 16:06)
Organised by: Logo
Congress Presentation Part of: Right and left heart disease: which comes first? Pulmonary Hypertension ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Matteo Toma

IRCCS Policlinic San Martino, Genoa (Italy)

4 More presentations in this session

Presentation thumbnail
Validation of the OPTICS and H2FPEF risk scores for post-capillary pulmonary hypertension in an asian cohort
Mr H. Jiang (Singapore, SG)
Abstract Slides Video
Presentation thumbnail
PAH-specific treatment for patients with combined pre- and post-capillary pulmonary hypertension
Doctor T. Hofbauer (Vienna, AT)
Abstract Slides Video
Presentation thumbnail
Pulmonary hypertension in patients with heart failure with reduced ejection fraction: impact of the new definition of pulmonary hypertension
Doctor S. Vysocansky (Bratislava, SK)
Abstract Slides Video
Presentation thumbnail
Pulmonary hypertension associated with left heart disease among hospitalized patients: analysis of the Nationwide Inpatient Sample
Mr I. Farmakis (Munich, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Right and left heart disease: which comes first?
Video

The Event

Event poster

ESC Congress 2023

27 August 2023 15:57 CET
You may be interested in
thumbnail
Congress Session
Right and left heart disease: which comes first?
thumbnail
Congress Session
Phenotyping and risk stratification in pulmonary arterial hypertension
thumbnail
Congress Session
Pulmonary hypertension in patients with cardiopulmonary comorbidities: the challenges

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources